Xu Dong Yin
Directeur/Membre du Conseil chez LAEKNA, INC.
Profil
Xu Dong Yin is currently a Director at Novartis New Zealand Ltd., NeuExCell Therapeutics, Inc., and Laekna, Inc. He previously worked as a Director Manager at Boston Consulting (Shanghai) Co. Ltd.
from 2000 to 2004, as the President-AstraZeneca China at AstraZeneca PLC from 2004 to 2011, and as the Head-Asia Pacific, Middle East & Africa Regions at Novartis Pharmaceuticals Corp.
from 2011 to 2021.
Dr. Yin holds an MBA from Harvard University, a doctorate from Stanford University, and an undergraduate degree from Peking University.
Postes actifs de Xu Dong Yin
| Sociétés | Poste | Début |
|---|---|---|
| LAEKNA, INC. | Directeur/Membre du Conseil | - |
Novartis New Zealand Ltd.
 Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | - |
NeuExCell Therapeutics, Inc.
 NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Xu Dong Yin
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/12/2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2011 |
| Boston Consulting (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01/02/2004 |
Formation de Xu Dong Yin
| Harvard University | Masters Business Admin |
| Stanford University | Doctorate Degree |
| Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| LAEKNA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis New Zealand Ltd.
Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Distribution Services |
NeuExCell Therapeutics, Inc.
NeuExCell Therapeutics, Inc. Medical/Nursing ServicesHealth Services NeuExCell Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in State College, PA. | Health Services |
| Boston Consulting (Shanghai) Co. Ltd. |
